The CGHMC RERB meets via Zoom or face-to face every 3RD or 4TH Thursday of the month and releases its approval/query letter 1 week after the said RERB meeting. Turnaround time from submission to approval is usually around 2 to 3 months.

For Initial and post-approval review of industry-sponsored and investigator initiated protocols submitted on or before the 1st week of the month will be included in the same month’s RERB meeting

No, but PI may be called to join the meeting for a clarificatory interview to answer and clarify questions raised by the Board.

The validity of the ethical approval is for one (1) year only, hence, the Principal Investigator should submit progress report and apply for a Continuing Review.

Upon submission of the protocol.

The Sponsor prepares the tri-partite clinical trial agreement to be signed by the Sponsor, Principal Investigator and Chinese General Hospital and Medical Center (CGHMC). CGHMC signatory is SAMUEL ANG, M.D., Medical Director. The RERB is NOT a signatory of the CTA. The CTA undergoes RERB endorsement and legal review prior to the approval of the Medical Director.